ROCHESTER, N.Y. and BOSTON, Oct. 15, 2013 (GLOBE NEWSWIRE) -- Caliber Imaging & Diagnostics (OTCQB:LCDX), formerly Lucid, Inc., announced that the Company's VivaScope® cellular imaging system will be featured at the 1st Latin American Congress of Dermoscopy on October 17-18, 2013 in Sao Paulo, Brazil. The FDA-cleared VivaScope devices provide patients the option of a painless, noninvasive optical skin biopsy in lieu of expensive and painful traditional skin biopsy while also having potential applications in several other medical and research specialties.
Caliber I.D.'s Brazilian distribution partner, Emdutos, is set to exhibit at the conference and will provide live demonstrations of the VivaScope® 3000 portable handheld confocal microscope, which has been designed to provide access to imaging lesions in areas of the body, such as eyes, ears and scalp—or anywhere else on the body—that are not easily reached with other confocal devices.
Additionally, Giovanni Pellacani, M.D., a professor of dermatology at the University of Modena and Reggio Emilia in Italy, will conduct a series of talks as well as a roundtable session at the conference on the topic of confocal microscopy.
L. Michael Hone, Chief Executive Officer of Caliber I.D., said, "The market for confocal microscopy in healthcare—both in Latin America and around the world—is significant and growing rapidly. We are eager to have the VivaScope system presented to the global opinion leaders who will be attending this groundbreaking conference, and are grateful that our Brazilian distributor will be demonstrating the VivaScope 3000 device there. We believe the advantages of VivaScope will resonate with a wide cross-section of attendees from across the globe."
About the 1st Latin American Congress of Dermoscopy
The 1st Latin American Congress of Dermoscopy was organized by the Dermoscopy Chapter of the Ibero-Latin American College of Dermatology. With the support of the Brazilian Society of Dermatology, the Brazilian Society for Dermatologic Surgery, the Brazilian Melanoma Group and the Center for Skin Cancer Hospital AC Camargo, the Congress offers an innovative scientific program covering all fields of application of dermoscopy, and attracting practitioners of dermoscopy from around the world.
About Caliber Imaging & Diagnostics
Caliber Imaging & Diagnostics' platform of products offer increased productivity from the research laboratory to the doctor's office or the surgeon's operating room. Caliber I.D.'s platform of products provide precise accuracy, consistent reliability, and online backup that all combine to lead to better patient care. For more information about Caliber I.D. and its products, please visit www.caliberid.com.
VivaScope® is a registered trademark of Caliber Imaging & Diagnostics.
This press release contains "forward looking statements" within the meaning of the Securities Litigation Reform Act of 1995. These statements include but are not limited to our plans, objectives, expectations and intentions and other statements that contain words such as "expects," "contemplates," "anticipates," "plans," "intends," "believes," "assumes" and variations of such words or similar expressions that predict or indicate future events or trends, or that do not relate to historical matters. These statements are based on our current beliefs or expectations and are inherently subject to significant known and unknown uncertainties and changes in circumstances, many of which are beyond our control. There can be no assurance that our beliefs or expectations will be achieved and actual results may differ materially from our beliefs or expectations due to financial, economic, business, regulatory and other factors or conditions affecting us or our industry in general, as well as more specific risks and uncertainties facing us, such as those set forth in the Risk Factors section of the Forms 10-Q and 10-K filed by us with the Securities and Exchange Commission.
CONTACT: Richard Pulsifer
Chief Financial Officer
Dian Griesel Inc.Cheryl Schneider
Dian Griesel Inc.Susan Forman or Laura Radocaj
Source: Caliber Imaging & Diagnostics, Inc.